imatinib mesylate has been researched along with Gallstones in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nayak, HK; Padhi, S | 1 |
| Alimena, G; Breccia, M; D'Andrea, M | 1 |
2 other study(ies) available for imatinib mesylate and Gallstones
| Article | Year |
|---|---|
Primary Extragastrointestinal Stromal Tumours in the Hepatobiliary Tree and Telocytes.
Topics: Actins; Adult; Aged; Antigens, CD34; Antineoplastic Agents; Biomarkers, Tumor; Female; Gallbladder; Gallstones; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver; Male; Middle Aged; Pancreas; Proto-Oncogene Proteins c-kit; Telocytes; Treatment Outcome; Vimentin | 2016 |
Can nifedipine and estrogen interaction with imatinib be responsible for gallbladder stone development?
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Drug Interactions; Estrogens; Female; Gallstones; Humans; Imatinib Mesylate; Male; Nifedipine; Piperazines; Pyrimidines; Tocolytic Agents | 2005 |